Analytical Performance Requirements for Systems for Self-Monitoring of Blood Glucose With Focus on System Accuracy: Relevant Differences Among ISO 15197:2003, ISO 15197:2013, and Current FDA Recommendations
about
A Post-Marketing Surveillance Study to Evaluate Performance of the EXIMO™ Blood Glucose Monitoring System.Interferences and Limitations in Blood Glucose Self-Testing: An Overview of the Current Knowledge.Enzyme-Based Glucose Sensor: From Invasive to Wearable Device.Evaluation of accuracy dependence of Raman spectroscopic models on the ratio of calibration and validation points for non-invasive glucose sensing
P2860
Analytical Performance Requirements for Systems for Self-Monitoring of Blood Glucose With Focus on System Accuracy: Relevant Differences Among ISO 15197:2003, ISO 15197:2013, and Current FDA Recommendations
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Analytical Performance Require ...... nd Current FDA Recommendations
@ast
Analytical Performance Require ...... nd Current FDA Recommendations
@en
Analytical Performance Require ...... nd Current FDA Recommendations
@nl
type
label
Analytical Performance Require ...... nd Current FDA Recommendations
@ast
Analytical Performance Require ...... nd Current FDA Recommendations
@en
Analytical Performance Require ...... nd Current FDA Recommendations
@nl
prefLabel
Analytical Performance Require ...... nd Current FDA Recommendations
@ast
Analytical Performance Require ...... nd Current FDA Recommendations
@en
Analytical Performance Require ...... nd Current FDA Recommendations
@nl
P2093
P2860
P356
P1476
Analytical Performance Require ...... nd Current FDA Recommendations
@en
P2093
A. Baumstark
L. Heinemann
M. Rutschmann
P2860
P304
P356
10.1177/1932296815580160
P407
P577
2015-07-01T00:00:00Z